proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial

Sponsor
Teesside University
Study ID
NCT07800390
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Anxiety
  • Health Education
  • Prostate Cancer
  • Screening
  • Screening and Brief Interventions
  • Wellbeing

Eligibility Criteria

Sex
MALE
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • proState Cancer awareness education to pRomote Early screENing uptake — BEHAVIORAL
    The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours.
  • Control group — OTHER
    Existing information provided by health care provider, including media around prostate cancer.

Study Details

Prostate cancer is an issue of significant public health concern. Yet in low- and middle-income countries like Nigeria, men are adversely affected due to factors including poor early prostate cancer screening uptake. Yet a gap remains in addressing this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced workshop intervention called "proState Cancer awareness education to pRomote Early screENing uptake (SCREEN) with men who are not or partially up to date with their screening. The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours. The proposed study also aims to pilot and test the instrument to determine its effectiveness and cost-effectiveness, including the mechanism by which the intervention might work.

Key Dates

First listed
Sep 2, 2026
Start date
Sep 15, 2026
Status verified
Aug 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
74 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: proState Cancer awareness education to pRomote Early screENing uptake (SCREEN)
    2 hour worksop session to foster awareness and encourage screening uptake
  • Active Comparator: Control group
    The control group will receive intervention as usual. This may be in the form of existing prostate cancer screening information provided in hospitals, media and health centres.

Primary Outcome Measure

Service Satisfaction Scale [ Time Frame: At the end of intervention (day 2) ]

Central Contacts

Find similar trials

Nationwide
Prostate cancer trialsOncology trialsProstate oncology trialsMen's health trialsUrology trials

Related Studies